Trials / Completed
CompletedNCT01376128
Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 96 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- —
Summary
The objectives of this survey was to retrospectively collect and evaluate the information on the efficacy and safety of PAXIL tablets ("PAXIL", hereinafter) in pediatric subjects (aged under 18) with panic disorder under conditions of actual use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-02-01
- Completion
- 2009-05-01
- First posted
- 2011-06-20
- Last updated
- 2017-05-22
Source: ClinicalTrials.gov record NCT01376128. Inclusion in this directory is not an endorsement.